Introduction: autism spectrum disorder (ASD) encompasses different syndromes characterized by neurodevelopmental disorders with some fundamental characteristics, which can manifest together or separately, including, difficulty in socializing, restrictive and repetitive behavior patterns. The treatment proposed to combat ASD includes the pharmacological ones, especially with antipsychotic drugs for controlling neurological/behavioral symptoms and the non-pharmacological
measures, mainly behavioral therapies. In recent years, the increase of prevalence generated a miscellany of complementary and alternative medicine (CAM), promising satisfactory results. Material and Methods: a systematic review was performed based on articles published from October 1976 to October 2016. Medline, Science Direct, Web of Science and Scopus databases were considered. The key terms used were “ASD”, “Asperger”, “autism”, “healing plants”, “herbal medicine” and “medicinal plants”. In order to be considered in this analysis, were used two inclusion criteria: be performed with crude extract, mixture of herbs or isolated fractions from herbal extracts and have been published in English, Spanish or Portuguese. To ensure the consistency of the process, the recommendations of the
Cochrane Collaboration and PRISMA statement were followed. Two independent reviewers selected the articles according to the inclusion/exclusion criteria. The aim of this systematic review is to give an overview of the use of herbal medicine in ASD. Results: The literature search identified 3157 studies and in this review were included the total of 23 studies. The administration of different herbals preparations
has been used to treat the ASD symptoms. Some of them, including Ginkgo Biloba EGb 761 associated with risperidone and Panax ginseng, did not lead to improvements of the ASD symptoms. On the other hand, preparations as
Yokukansan (YKS) may be effective for the treatment of irritability and hyperactivity. A total of 64 medicinal species were cited in these works, which, lack information on the clinical effectiveness of the compounds and on the preclinical adequate model. Discussion and Conclusion: Although some preliminary results are promising, critically validated models were conducted, with different methodologies and small number of patients. Only after standardization of these preparations and mapping the major secondary metabolites, appropriate clinical trials can definitively prove
the effectiveness of these agents as an add-on treatment of ASD symptoms.


Gordon-Lipkin, E. et al; Whittling Down the Wait time: Exploring Models to Minimize the Delay from Initial Concern to Diagnosis and Treatment of Autism Spectrum Disorder. Pediatr. Clin. North. Am., 2016, 63(5), 851-859.

Murphy, C. M. et al; Autism spectrum disorder in adults: diagnosis, management, and health services development. Neuropychiatr. Dis. Treat., 2016, 12, 1669-1686.

Ziats, M. N. et al; The Evolving Diagnosis and Genetic Landscapes os Autism Spectrum Disorder. Front. Genet., 2016, 7(65), 1-6.

Pantelis, P. C. et al; Estimation of the prevalence of autism spectrum disorder in South Korea, revisted. Autism, 2016, 20(5), 517-527.

Fitzpatrick, S.E. et al; Aggression in autism spectrum disorder: presentation and treatment options. Neuropsychiatr. Dis. Treat., 2016,12, 1525-38.

Ichikawa, K. et al; TEACH-based group social skills training for children with highfunctioning autism: a pilot randomized controlled trial. Biopsychosoc. Med., 2013, 7(14), 1-8.

Fernandes, F.D. et al; Applied behavior analysis and autism spectrum disorders: literature review.Codas, 2013, 25(3), 289-296.

Goldson, E. Advances in Autism-2016. Adv. Pediatr., 2016, 63(1), 333-355

Levy, S.E., et al. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child. Adolesc. Psychiatr. Clin. N. Am., 2015, 24(1) 117-143.

Green, V.A., et al. Internet survey of treatments used by parents of children with autism. Res. Dev. Disabil, 2006, 27(1), 70-84.

Perrin, J.M., et al. Complementary and alternative medicine use in large pediatric autism sample. Pediatrics, 2012, 130(2), S77-S82.

Lange, K.W., et al. Gluten-free and caseinfree diets in the therapy of autism. Curr. Opin. Clin. Nutr. Metab. Care., 2015, 18(6), 572-575

Pandey, M, et al. Phytomedicine: an ancient approach turning into future potential source of therapeutics. J. Pharmacognosy Phytother., 2011, 3(1), 113-117.

Higgins, J. P. T. et al; Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Colaboration, 2011. www.handbook.cochrane.org

Liberati, A. et al; The PRISMA statement for reporting systematic reviews and meta-analyses os studies that evaluated health care interventions: explanation and elaboration. PLOS Med., 2009, 6(7), 1-28.

Banji, D. et al; Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain. Res., 2011, 1410, 141-151.

Sandhya, T. et al; Wettst Amelioration of behavioral aberrations and oxidative

markers in sodium valproate induced autism in animals. Neurochem. Res., 2012,

(5), 1121-1131.

Kim, P. et al; Effects of Corian Red Ginseng extract on neural tube defects and

impairment of social interaction induced by prenatal exposure to valproic acid. Food

chain chem. Toxical.,2013, 51, 288-296.

Muneoka, K. et al; Modern/ offspring co-administration of the traditional herbal

remedy yokukansa during the nursing period influences grooming and cerebellar

serotonin levels in a rat model of neurodevelopmental disorders. Cerebellum.,

,14(2), 86-96.

Gonzales, E. L. et al; Supplementation of corian red ginseng improves behavior

deviations in animal models of autism. Food. Nuter. Res., 2016, 60, 1-10.

Morakotsriwan, N. et al; Oxidative Stress Status, and Histopathological Changes

in Cerebellum of Valproic Acid Rat Model of Autism are Improved by The CombineD Extract of Purple Rice and Silk Warm Pupae. Oxid. Med. Cel. Longev., 2016, 2016, 1-

Hasanzadeh, E. et al; A doblue-blind placebo controlled trial of Ginkgo Biloba

added to risperidone in patients with autistic disorders. Child Psychiatry Hun. Dev.,

, 43(5), 674-682.

Niederhofer, H.; First preliminary results of an observation of Ginkgo Biloba

treating patients with autistic disorders. Phytother. Res., 2009,23(11), 1645-1646.

Niederhofer, H. St Jhon’s wort treating patients with autistic disorders.

Phytother. Res., 2009,23(11), 1521-1523.

Niederhofer, H.; First preliminary results of an observation of an observations of

Panax Ginseng treatments in patients with autistic disorders. J. Diet. Suppl.,

,6(4), 342-346.

Chan, A.S. et al; An intranasal herbal medicine improves executive functions

and activates the underlying neural network in children with autism. Res. Autism

Spectr. Disords., 2014, 8(6), 681-691.

Wake, R. et al; J. Yokukanasn for irritability associated with pervasive

developmental disorder in children and adolescents: a 12-week prospective openlabel

study. J. Child. Adolsc. Psychopharmacol.,2013, 23(5), 239-336.

Zhang, J. A review of Autism Spectrum Disorders (ASD) from a perspective of

Classical Chinese Medicine (CCM). J. Tradit. Chin. Med. 2010, 30(1), 53-59.

Bahmani, M. et al; M. Autism: Pathopsysiology and Promising Herbal Remedies.

Curr. Pharm. Des., 2016, 22(3), 277-285.

Hamidpour, M. et al; Chemistry, Pharmacology and Medicinal Property of Sage

(Salvia) to prevent and cure illnesses such as obesity diabetes depression,

dementia, lupus, autism, heart, disease and cancer. J. Tradit. Complements. Med.,

, 4(2) 82-88.

Weber, W. et al; Complementary and alternative medical therapies for

attention-deficit/hyperactivity disorder and autism. Pediatr. Clean. North. Am., 2007,

(6) 983-1006.

Rezapour, S. et al; Herbal medicine’s a new hope for autism therapy. J. Herb.

Med. Pharmacol., 2016, 5(3), 89-91.

Hadland, S. et al; Medical marijuana review of the science and implication for

developmental-behavioral pediatric practci. J. Dev. Behav. Pediatr., 2015, 36(2),


Wong, H. H. L. et al; Patrrerns of complementary and alternatives medical

therapy use in children diagnosed with autism spectrum disorders. J. Autism Dev.

Disord. 2006, 36, 901-909.

Rasool, M. et al; Recents updates in the treatments of neurodegenerative

disorders using natural compounds. Evid. Based Complement. Alternat. Med., 2014,

, 1-7.

Guenne, S. et al; The relevance of asteraceae family plant in most of the

neurophsyatric disorders treatment. Int. J. Phytomedicne.,2016, 8(2), 176-182


  • Não há apontamentos.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.